Cite
Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.
MLA
Fares, Sami, et al. “Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.” Cancers, vol. 16, no. 8, Apr. 2024, p. 1453. EBSCOhost, https://doi.org/10.3390/cancers16081453.
APA
Fares, S., Wehrle, C. J., Hong, H., Sun, K., Jiao, C., Zhang, M., Gross, A., Allkushi, E., Uysal, M., Kamath, S., Ma, W. W., Modaresi Esfeh, J., Linganna, M. W., Khalil, M., Pita, A., Kim, J., Walsh, R. M., Miller, C., Hashimoto, K., & Schlegel, A. (2024). Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma. Cancers, 16(8), 1453. https://doi.org/10.3390/cancers16081453
Chicago
Fares, Sami, Chase J. Wehrle, Hanna Hong, Keyue Sun, Chunbao Jiao, Mingyi Zhang, Abby Gross, et al. 2024. “Emerging and Clinically Accepted Biomarkers for Hepatocellular Carcinoma.” Cancers 16 (8): 1453. doi:10.3390/cancers16081453.